Hydroxypropyl-sulfobutyl-β-cyclodextrin improves the oral bioavailability of edaravone by modulating drug efflux pump of enterocytes.
about
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trialsEffects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigationLipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation.Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement.
P2860
Hydroxypropyl-sulfobutyl-β-cyclodextrin improves the oral bioavailability of edaravone by modulating drug efflux pump of enterocytes.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Hydroxypropyl-sulfobutyl-β-cyc ...... ug efflux pump of enterocytes.
@ast
Hydroxypropyl-sulfobutyl-β-cyc ...... ug efflux pump of enterocytes.
@en
type
label
Hydroxypropyl-sulfobutyl-β-cyc ...... ug efflux pump of enterocytes.
@ast
Hydroxypropyl-sulfobutyl-β-cyc ...... ug efflux pump of enterocytes.
@en
prefLabel
Hydroxypropyl-sulfobutyl-β-cyc ...... ug efflux pump of enterocytes.
@ast
Hydroxypropyl-sulfobutyl-β-cyc ...... ug efflux pump of enterocytes.
@en
P2093
P356
P1476
Hydroxypropyl-sulfobutyl-β-cyc ...... rug efflux pump of enterocytes
@en
P2093
P304
P356
10.1002/JPS.23807
P407
P50
P577
2013-12-05T00:00:00Z